Συγγραφείς:
Karamitrousis, E.
Balgkouranidou, I.
Xenidis, N.
Amarantidis, K.
Biziota, E.
Koukaki, T.
Trypsianis, G.
Karayiannakis, A.
Bolanaki, H.
Chatzaki, E.
Kolios, G.
Lianidou, E.
Lambropoulou, M.
Kakolyris, S.
Λέξεις-κλειδιά:
capecitabine; docetaxel; oxaliplatin; Ras association domain family protein 1A; transcription factor Sox17; antineoplastic agent; capecitabine; docetaxel; oxaliplatin; RASSF1 protein, human; signal transducing adaptor protein; SOX17 protein, human; transcription factor Sox; tumor suppressor protein; WIF1 protein, human, apoptosis; blood sampling; cancer chemotherapy; cancer patient; cell cycle regulation; cell interaction; disease exacerbation; DNA methylation; DNA repair; genetic association; human; Letter; metastasis; oncogene; phenotype; predictive value; priority journal; promoter region; signal transduction; stomach cancer; treatment response; wif 1 gene; DNA methylation; drug effect; gene expression regulation; genetics; metabolism; promoter region; stomach tumor, Adaptor Proteins, Signal Transducing; Antineoplastic Agents; Capecitabine; DNA Methylation; Docetaxel; Gene Expression Regulation; Humans; Oxaliplatin; Promoter Regions, Genetic; SOXF Transcription Factors; Stomach Neoplasms; Tumor Suppressor Proteins
